Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium

Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC/VI;   Drug: UMEC/VI matching placebo;   Drug: Tiotropium;   Drug: Tiotropium matching placebo;   Drug: Indacaterol;   Drug: Indacaterol matching placebo;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineActive, not recruiting - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials